Stay updated on Ivermectin in Severe COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Ivermectin in Severe COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ivermectin in Severe COVID-19 Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-28T15:16:56.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner announces an NIH transition and says both “Super Intelligence” and “Artificial Intelligence” may appear across NIH content during the transition.
    Difference
    1%
    Check dated 2026-10-21T17:17:25.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-14T16:55:09.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T17:11:54.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now displayed, replacing the study results content; the page header shows a 403 message and a Home link while the detailed study information is no longer accessible.
    Difference
    22%
    Check dated 2026-09-23T19:54:31.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating an update to the page template or site software. The change does not alter the displayed study results or other user-facing content.
    Difference
    0.0%
    Check dated 2026-09-16T21:42:05.000Z thumbnail image

Stay in the know with updates to Ivermectin in Severe COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ivermectin in Severe COVID-19 Clinical Trial page.